Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADVISORY/Phase Forward Executives to Present at 21 CFR 11 and The FDA Guidance for Computerized Systems Conference.


Business/Technology Editors and Healthcare/Pharmaceutical Writers

ADVISORY...Monday (May 21)

--(BUSINESS WIRE)

Phase Forward

Who:   Phase Forward Incorporated, the Pioneer in Proven E-Process
       Solutions for Accelerating Global Pharmaceutical Development

What:  Dr. Paul Bleicher, founder, chairman and chief scientific
       officer of Phase Forward, to Chair the Conference, and Gilbert
       Benghiat, director of engineering of Phase Forward, to Present
       as Part of a Seminar on, "Archiving Data and Systems."

Where: Washington Marriott Hotel, Washington, D.C.

When:  Conference:       Monday, May 21 through Tuesday, May 22, 2001
       Presentation:     Tuesday, May 22 at 11:00 a.m. EDT


Hosted by the Drug Information Association, The 21 CFR CFR

See: Cost and Freight
 11 and the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 Guidance for Computerized computerized

adapted for analysis, storage and retrieval on a computer.


computerized axial tomography
see computed tomography.
 Systems Used in Clinical Trials conference will discuss various issues in the design, development, implementation, validation, and deployment of computer systems in clinical trials. Sessions will explore the implementation of clinical trial technology in further detail, such as the principles behind the new FDA Guidance on Computerized Systems in Clinical Trials and the challenges raised by these new technologies and applications.

Dr. Bleicher will serve as the program chairperson chairperson Chairman The head of an academic department. See 'Chair.', Cf Chief.  for this conference, outlining the conference agenda, which will consist of discussions ranging from clinical information technology, regulatory affairs Regulatory Affairs (RA), also called Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. Regulatory Affairs professionals usually have responsibility for the following general areas:
, and data assessment.

Gilbert Benghiat's presentation, "Electronic Source Documents: Who has Control?" will examine electronic source document technologies, such as Web-based data capture, remote data entry, certified copies those which are made or attested by officers having charge of the originals, and authorized to give copies officially.
- Abbot.

See also: Copy
, and palm pilots. In addition, Mr. Benghiat will discuss the regulatory issues for electronic source data.

Dr. Bleicher brings to Phase Forward more than 11 years of experience in the design, implementation and analysis of clinical trials from both the sponsor and clinical investigator A clinical investigator involved in a clinical trial is responsible for ensuring that an investigation is conducted according to the signed investigator statement, the investigational plan, and applicable regulations; for protecting the rights, safety, and welfare of subjects under  perspective. Before founding Phase Forward, Dr. Bleicher was vice president, Clinical Affairs at Alpha-Beta Technology, Inc.

Mr. Benghiat has more than 15 years of experience in bringing software products to market. Prior to joining Phase Forward, Mr. Benghiat managed NetCentric's Internet fax Using the Internet to send faxes. Fax servers accept an incoming fax message and route it to a fax server in the same locality as the destination fax machine. The fax server then makes a local telephone call to send the fax.  server development and Internet metering projects.

About Phase Forward

Phase Forward Incorporated is the pioneer in proven e-process solutions for accelerating global pharmaceutical development. Phase Forward's InForm(TM) software product uses Internet technologies to conduct and manage clinical trials efficiently and effectively. The InForm software product has been used in over 133 clinical trials worldwide. Its software and service solutions allow sponsors of clinical trials to eliminate the need to transcribe To copy data from one medium to another; for example, from one source document to another, or from a source document to the computer. It often implies a change of format or codes.  and process traditional paper data forms, to access global clinical trial data in real time, and to begin data analysis almost immediately after the last patient has visited the clinic. Phase Forward believes that use of its InForm software product by clinical trial sponsors has the potential to cut one to two years off the current seven to nine years it takes to bring new drugs to market, enabling them to increase their revenue potential. Phase Forward Incorporated, a privately held company privately held company

A firm whose shares are held within a relatively small circle of owners and are not traded publicly.
, is headquartered in Waltham, Mass. Additional information about Phase Forward is available at http://www.phaseforward.com.

Phase Forward, InForm and InForm Unplugged are trademarks or registered trademarks of Phase Forward Incorporated. All other trademarks may be the property of their respective owners.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 16, 2001
Words:511
Previous Article:ADVISORY/ Phase Forward's Paul Bleicher to Moderate Discussion At Data Standards for Clinical Development Conference.
Next Article:Razorfish Teams with Elsevier Science to Create the First Comprehensive Search Engine Dedicated to Science.



Related Articles
The role of FDA approval in drug cases.
Developing new smallpox vaccines. (Perspectives).
How to buck preemption in drug cases.
Research provides golden opportunity for physicians: An overview of clinical trials and how to conduct them. (Clinical Trials).
Impact of current Good Manufacturing Practices and emission regulations and guidances on the discharge of pharmaceutical chemicals into the...
Products that consumers inquire about. (U. S. Food and Drug Administration Center for Food Safety and Applied Nutrition).
UN politics: a rigged game; current appeals to increase U.S. influence at the UN to advance our national interests are dangerous ploys meant to draw...
An overview of drug development in the United States and current challenges.
Witter starts "Aseptic Processing & Packaging"; converts title to NL.
May 2005 update to the Commercial Bank Examination Manual.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles